No Data
No Data
Renalytix Requests Hearing With Nasdaq to Maintain Listing
Renalytix (RNLX) said Thursday it has submitted a request for a hearing with Nasdaq to present a plan to regain compliance with the stock market's listing requirements. The company said it has been no
Reported Earlier, Renalytix Fights Nasdaq Delisting With Strategic Plan, Trading Temporarily Safe
Renalytix plc (NASDAQ:RNLX) (LSE: RENX) announces that it has formally submitted a hearing request to the Nasdaq Hearings Panel (the "Panel"), which request has now stayed the suspension of theRenalyt
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
LONDON and NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ:RNLX) (LSE: RENX) announces that it has formally submitted a hearing request to the Nasdaq Hearings Panel (the "Panel"), which request has
ADRs Close Lower; Renalytix Declines 29%
This article was automatically generated by MarketWatch using technology from Automated Insights. International stocks trading in New York closed lower on Wednesday, as the S&P/BNY Mellon index of Am
Renalytix to Appeal Nasdaq Delisting Over Non-compliance
Renalytix (2O9.F) plans to appeal the Nasdaq Stock Market's decision to delist the company for non-compliance with listing requirements, according to a Tuesday release. The AI-based in-vitro diagnosti
Form 8.5 (EPT/RI)-Renalytix Plc
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.